Close
Nordic 9Nordic 9

Cinclus Pharma (private company)

Sweden cincluspharma.com
See something wrong or missing? Let us know
Offices:Stockholm
Industry:BiotechHealth servicesPharma
Business model:B2B

Cinclus Pharma AB is a clinical stage pharma company developing small molecules for the treatment of gastric acid related diseases. Its drug candidate X842 has successfully completed a phase I clinical study.

Investors: we tracked 8 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 50.57M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Cinclus Pharma

Name Criteria
United Kingdom Causaly
77%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Italy Kither Biotech
77%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
France PEP-Therapy
72%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 2
  • At least one other investor: found 2
Sweden iCellate
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Octarine Bio
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
United Kingdom ReViral
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Synklino
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top